Literature DB >> 26544923

LPS-RS attenuation of lipopolysaccharide-induced acute lung injury involves NF-κB inhibition.

Marwa E Abdelmageed1,1, Mohammed S El-Awady1,1, Mona Abdelrahim1,1, Ghada M Suddek1,1.   

Abstract

In this study, we studied the effect of lipopolysaccharide from Rhodobacter sphaeroides (LPS-RS), an inhibitor of Toll-like receptor 4 (TLR4), in LPS-induced acute lung injury (ALI). Male Sprague-Dawley rats were treated with LPS-RS (0.1 mg/kg body mass, by intraperitoneal (i.p.) injection) 1 h before LPS injection (10 mg/kg, i.p.). Bronchoalveolar lavage fluid (BALF) and lung tissues were collected 24 h later to determine total and differential cell count, total protein content, levels of lactate dehydrogenase (LDH), histopathological changes, markers of oxidative stress, and mRNA expression of the inhibitory protein nuclear factor kappaB-α (NFκBIA) and TLR4. Additionally, rings of pulmonary artery were isolated for measuring vascular reactivity. LPS-induced ALI was indicated by increases in total and differential cell count, total protein, and LDH in BALF, and increased lung levels of malondialdehyde (MDA), as well as decreased activity of reduced glutathione (GSH) and superoxide dismutase (SOD). Moreover, LPS increased pulmonary artery contraction in response to phenylephrine (PE). Additionally, LPS downregulated mRNA expression of NFκBIA and upregulated mRNA expression of TLR4. LPS caused a marked inflammation in the lung tissue, with tubercular granuloma and numerous neutrophils. Pretreatment with LPS-RS protected against LPS-induced ALI by decreasing total and differential cell count, total protein, and LDH in BALF, and increased pulmonary GSH content and SOD activity without affecting MDA content. Additionally, it decreased the elevated PE-induced pulmonary artery contraction. LPS-RS upregulated mRNA expression of NFκBIA and downregulated mRNA expression of TLR4. Moreover, LPS-RS prevented inflammation in lung tissues. In conclusion, pretreatment with LPS-RS protects against LPS-induced ALI in rats through its anti-inflammatory effects, possibly by decreasing the mRNA expression of TLR4 and increasing that of NFκBIA.

Entities:  

Keywords:  LPS-RS; NFκBIA; TLR4; acute lung injury; lipopolysaccharide; lésion pulmonaire aiguë

Year:  2015        PMID: 26544923     DOI: 10.1139/cjpp-2015-0219

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  11 in total

1.  Effect of Lipopolysaccharide from Rhodobacter sphaeroides on Inflammatory Pathway and Oxidative Stress in Renal Ischemia/Reperfusion Injury in Male Rats.

Authors:  M Aal-Aaboda; A R Abu Raghif; N R Hadi
Journal:  Arch Razi Inst       Date:  2021-10-31

2.  Renoprotective Potential of the Ultra-Pure Lipopolysaccharide from Rhodobacter Sphaeroides on Acutely Injured Kidneys in an Animal Model.

Authors:  M S Aal-Aaboda; A R Abu Raghif; N R Hadi
Journal:  Arch Razi Inst       Date:  2021-12-30

3.  Hyperphosphorylated tau self-assembles into amorphous aggregates eliciting TLR4-dependent responses.

Authors:  Jonathan X Meng; Yu Zhang; Dominik Saman; Arshad M Haider; Suman De; Jason C Sang; Karen Brown; Kun Jiang; Jane Humphrey; Linda Julian; Eric Hidari; Steven F Lee; Gabriel Balmus; R Andres Floto; Clare E Bryant; Justin L P Benesch; Yu Ye; David Klenerman
Journal:  Nat Commun       Date:  2022-05-16       Impact factor: 17.694

4.  Anti-Oxidant and Anti-Inflammatory Effects of Lipopolysaccharide from Rhodobacter sphaeroides against Ethanol-Induced Liver and Kidney Toxicity in Experimental Rats.

Authors:  Eman T Mehanna; Al-Shimaa A Ali; Fatma El-Shaarawy; Noha M Mesbah; Dina M Abo-Elmatty; Nora M Aborehab
Journal:  Molecules       Date:  2021-12-08       Impact factor: 4.411

5.  Nuciferine Ameliorates Inflammatory Responses by Inhibiting the TLR4-Mediated Pathway in Lipopolysaccharide-Induced Acute Lung Injury.

Authors:  Haichong Wu; Yaping Yang; Shuai Guo; Jing Yang; Kangfeng Jiang; Gan Zhao; Changwei Qiu; Ganzhen Deng
Journal:  Front Pharmacol       Date:  2017-12-21       Impact factor: 5.810

6.  HMGB1 participates in LPS‑induced acute lung injury by activating the AIM2 inflammasome in macrophages and inducing polarization of M1 macrophages via TLR2, TLR4, and RAGE/NF‑κB signaling pathways.

Authors:  Jing Wang; Ruiting Li; Zhiyong Peng; Bo Hu; Xin Rao; Jianguo Li
Journal:  Int J Mol Med       Date:  2019-11-12       Impact factor: 4.101

Review 7.  Role of HMGB1 in Chemotherapy-Induced Peripheral Neuropathy.

Authors:  Fumiko Sekiguchi; Atsufumi Kawabata
Journal:  Int J Mol Sci       Date:  2020-12-31       Impact factor: 5.923

8.  Lipopolysaccharide from Rhodobacter spheroids modulate toll-like receptors expression and tissue damage in an animal model of bilateral renal ischemic reperfusion injury.

Authors:  Munaf Aal-Aaboda; Ahmed Rahma Abu Raghif; Rihab Hameed Almudhafer; Najah Riesh Hadi
Journal:  J Med Life       Date:  2022-05

9.  Hepatocyte Nuclear Factor 1α Proinflammatory Effect Linked to the Overexpression of Liver Nuclear Factor-κB in Experimental Model of Chronic Kidney Disease.

Authors:  Elzbieta Sucajtys-Szulc; Alicja Debska-Slizien; Boleslaw Rutkowski; Marek Szolkiewicz; Julian Swierczynski; Ryszard Tomasz Smolenski
Journal:  Int J Mol Sci       Date:  2022-08-10       Impact factor: 6.208

10.  Effects of Anti-IL-17 on Inflammation, Remodeling, and Oxidative Stress in an Experimental Model of Asthma Exacerbated by LPS.

Authors:  Leandro do Nascimento Camargo; Renato Fraga Righetti; Luciana Ritha de Cássia Rolim Barbosa Aristóteles; Tabata Maruyama Dos Santos; Flávia Castro Ribas de Souza; Silvia Fukuzaki; Maysa Mariana Cruz; Maria Isabel Cardoso Alonso-Vale; Beatriz Mangueira Saraiva-Romanholo; Carla Máximo Prado; Mílton de Arruda Martins; Edna Aparecida Leick; Iolanda de Fátima Lopes Calvo Tibério
Journal:  Front Immunol       Date:  2018-01-05       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.